PPMD’s investment and additional funds, including from Duchenne UK and How Women Invest, represent $1.42 million in total support for MyoGene. This funding commitment may be leveraged for additional ...

Stanford Medicine researchers found that a smartphone could monitor patients with two types of muscular dystrophy as well as ...

The University at Albany and Virginia Commonwealth University were awarded a $6.5 million NIH grant to establish a federal ...

Detailed price information for Edgewise Therapeutics Inc (EWTX-Q) from The Globe and Mail including charting and trades.

The search for a treatment for limb-girdle muscular dystrophy was started by the family of former Bank of America Corp. CEO ...

BridgeBio said an experimental therapy for a rare form of muscular dystrophy succeeded in a key trial, potentially setting up ...

BridgeBio Pharma shares surge on positive BBP-418 trial results for limb-girdle muscular dystrophy. Read more here.

Image credit: saepul_bahri / Shutterstock.com. BridgeBio Pharma will seek US approval of its limb-girdle muscular dystrophy (LGMD) small molecule after the drug met its endpoints in a pivotal Phase ...

Researchers from Leiden University Medical Center and the University of Florida have found hundreds of blood proteins in ...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is one of the best small cap stocks with the highest upside. H.C. Wainwright ...

BECKER — The ROCORI football team is too much for opponents this fall. The Spartans have too many weapons, too many schemes and too much depth for most of their opponents. Against Becker on Friday in ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...